Description

TRIPHAGE PG2 TABLET is an advanced fixed-dose combination therapy containing Pioglitazone and Glimepiride, designed to offer optimal glycemic control in patients with Type 2 Diabetes Mellitus. It is indicated for use when monotherapy is inadequate in maintaining blood glucose levels.

• Glimepiride is a sulfonylurea that stimulates insulin release from pancreatic beta cells, helping reduce postprandial and fasting blood glucose.

• Pioglitazone is a thiazolidinedione that improves insulin sensitivity in peripheral tissues and reduces hepatic glucose output.

Together, these agents provide a synergistic effect, enhancing insulin action and improving glucose uptake across multiple organs.

Oral Antidiabetic Combination

• Glimepiride: Stimulates insulin secretion by acting on ATP-sensitive potassium channels in beta cells of the pancreas.

• Pioglitazone: Activates PPAR-γ receptors, improving insulin sensitivity and glucose uptake in adipose tissue and muscle, while decreasing hepatic glucose production.

• Type 2 Diabetes Mellitus (when monotherapy is inadequate)

• Patients requiring dual oral antidiabetic therapy

• Suitable for improving HbA1c levels in insulin-resistant patients

• Dual-action approach for better glycemic control

• Reduces both fasting and post-meal blood sugar levels

• Enhances insulin sensitivity and pancreatic insulin release

• Convenient once-daily dosing

• Helps delay the need for insulin therapy in diabetic patients

• Typically administered once daily, preferably with breakfast

• Dosage to be individualized based on patient response and physician’s recommendation

• Blood glucose monitoring is essential to determine efficacy and safety

• Monitor liver function regularly due to Pioglitazone component

• Use with caution in patients with heart failure

• Risk of hypoglycemia, especially in elderly or those with renal impairment

• Not recommended for Type 1 diabetes or diabetic ketoacidosis

• Periodic monitoring of HbA1c and blood glucose is advised

• Hypoglycemia

• Weight gain

• Edema

• Headache

• Muscle pain

• Upper respiratory tract infections

At BLUEPILL EXPRESS, we pride ourselves on delivering pharmaceutical excellence through internationally certified facilities. TRIPHAGE PG2 TABLET is manufactured under WHO-GMP and ISO standards, ensuring safety, efficacy, and global compliance.

We are a global exporter of all types of medicines, supplying high-quality pharmaceutical products to markets across Asia, Africa, Latin America, CIS, and the Middle East. Our commitment to regulatory support, private labeling, and custom packaging makes us a preferred partner in third-party manufacturing.